Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice

Abstract

Aims/hypothesis Acetyl coenzyme A acetyltransferase (ACAT), also known as acetoacetyl-CoA thiolase, catalyses the formation of acetoacetyl-CoA from acetyl-CoA and forms part of the isoprenoid biosynthesis pathway. Thus, ACAT plays a central role in cholesterol metabolism in a variety of cells. Here, we aimed to assess the effect of hepatic Acat2 overexpression on cholesterol metabolism and systemic energy metabolism. Methods We generated liver-targeted adeno-associated virus 9 (AAV9) to achieve hepatic Acat2 overexpression in mice. Mice were injected with AAV9 through the tail vein and subjected to morphological, physiological (body composition, indirect calorimetry, treadmill, GTT, blood biochemistry, cardiac ultrasonography and ECG), histochemical, gene expression and metabolomic analysis under normal diet or feeding with high-fat diet to investigate the role of ACAT2 in the liver. Results Hepatic Acat2 overexpression reduced body weight and total fat mass, elevated the metabolic rate, improved glucose tolerance and lowered the serum cholesterol level of mice. In addition, the overexpression of Acat2 inhibited fatty acid, glucose and ketone metabolic pathways but promoted cholesterol metabolism and changed the bile acid pool and composition of the liver. Hepatic Acat2 overexpression also decreased the size of white adipocytes and promoted lipid metabolism in white adipose tissue. Furthermore, hepatic Acat2 overexpression protected mice from high-fat-diet-induced weight gain and metabolic defects Conclusions/interpretation Our study identifies an essential role for ACAT2 in cholesterol metabolism and systemic energy expenditure and provides key insights into the metabolic benefits of hepatic Acat2 overexpression. Thus, adenoviral Acat2 overexpression in the liver may be a potential therapeutic tool in the treatment of obesity and hypercholesterolaemia. Graphical abstract

Exploring the Rumen Microbiota and Serum Metabolite Profile of Hainan Black Goats with Different Body Weights before Weaning

“…Furthermore, elevated serum glucose levels have been implicated in increasing substrate concentrations across various metabolic pathways. This enhances the synthesis of TG and TC in serum, factors integral to growth, development, and metabolism, as supported by studies from Ma et al [44] and Schade et al [45]. A noteworthy aspect of our study is the Spearman analysis, which revealed a simultaneous and positive correlation between glucose, TG, and TC and the relative abundance of specific rumen bacteria, namely Prevotellaceae_UCG-001 and Prevotellaceae_UCG-004.…”

ACAT2 may be a novel predictive biomarker and therapeutic target in lung adenocarcinoma

“…However, very little is known about other mechanisms. Recently, a new study has shown that the inflammatory responses or liver stress resulting from ACAT2 overexpression also inhibit the metabolic pathways of glycolytic, TG synthesis, mitochondrial‐related and ketone body metabolism, but the upregulated genes participate in the metabolism of cholesterol, particularly the biosynthesis pathway of bile acid 15 . ACAT2 is significantly upregulated, and promotes cancer cell growth and progression of CRC 8 .…”

The Role of Proton-Coupled Amino Acid Transporter 2 (SLC36A2) in Cold-Induced Thermogenesis of Mice

“…Last, we used KO mice to perform in vivo loss-of-function studies of SLC36A2 and SLC36A3. However, the gain-of-function study through generating overexpression models, especially tissue specific overexpression by transgenic mice or virus injection are still required [ 48 , 49 ]. Thus, future efforts which focus on the tissue specificity of SLC36As will be the next direction.…”